Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia.

Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia.

Show other versions (1)

BACKGROUND: Proton pump inhibitors (PPI) are among the most widely prescribed drugs to treat gastric acid-related disorders. PPI-induced hypomagnesaemia, a defect in intestinal absorption of Mg(2+) , can be a severe side effect of chronic PPI use. AIM: To restore serum Mg(2+) concentrations in PPI-i...

Full description

Bibliographic Details
Main Authors:	Hess, M, de Baaij, J, Broekman, M, Bisseling, T, Haarhuis, B, Tan, A, Morsche, R, Hoenderop, J, Bindels, R, Drenth, J
Format:	Journal article
Language:	English
Published:	2016

Similar Items

Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia
by: Hess, M, et al.
Published: (2016)

Renal magnesium loss causing hypomagnesaemia and autonomous hyperparathyroidism.
by: Barakat, M, et al.
Published: (2004)

The effect of proton-pump inhibitors on development of arrhythmia and hypomagnesaemia after off-pump coronary artery bypass surgery
by: Hasan Abbaspour, et al.
Published: (2024-12-01)

'Lemonade legs': Why do some patients get profound hypomagnesaemia on proton-pump inhibitors?
by: Atkinson, N, et al.
Published: (2015)

Identification of SLC41A3 as a novel player in magnesium homeostasis.
by: de Baaij, J, et al.
Published: (2016)

Identification of SLC41A3 as a novel player in magnesium homeostasis.
by: de Baaij, J, et al.
Published: (2016)

Hypomagnesaemia Posing as Hypoparathyroidism
by: Sonia Nasreen Ahmad
Published: (2015-09-01)

Correction of Serum Potassium Level in Hypokalaemic Patients with Hypomagnesaemia and Normomagnesaemia
by: Azfar Athar Ishaqui, et al.
Published: (2017-09-01)

Magnesium deficiency prevents high-fat-diet-induced obesity in mice
by: Kurstjens, S, et al.
Published: (2018)

Diagnosis of Hypomagnesaemia in Heifer calves and Experimental Treatment with Magnesium Oxide and Basil &Thyme
by: Naglaa Farage Hassan, et al.
Published: (2023-12-01)

Hypomagnesaemia with varying degrees of extrarenal symptoms as a consequence of heterozygous CNNM2 variants
by: Willem Bosman, et al.
Published: (2024-03-01)

Proton-pump inhibitor use is associated with low serum magnesium concentrations
by: Danziger, John, et al.
Published: (2017)

Hypomagnesaemia – One Cause To Remember!
by: Ana Filipa Viegas, et al.
Published: (2022-11-01)

P2X6 knockout mice exhibit normal electrolyte homeostasis
by: De Baaij, J, et al.
Published: (2016)

Hypomagnesaemia: The esoteric foe in diabetes and diabetic peripheral neuropathy
by: Manoj Saluja, et al.
Published: (2023-01-01)

Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: The first four patients in Serbia
by: Peco-Antić Amira, et al.
Published: (2010-01-01)

Butyrate reduces cellular magnesium absorption independently of metabolic regulation in Caco-2 human colon cells
by: Lisanne M. M. Gommers, et al.
Published: (2022-11-01)

Monitoring of serum magnesium levels during long-term use of proton pump inhibitors in elderly japanese patients: is it really necessary or not?
by: Nobuhiko Nakamura, et al.
Published: (2022-12-01)

Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesaemia: Is There a Best Replacement Strategy?
by: Zeba Siddiqui, et al.
Published: (2021-10-01)

Hypomagnesaemia in Acute Exacerbation Chronic Obstructive Airway Disease; Association with Anthonisen’s Levels of Exacerbation
by: Javaira Aziz, et al.
Published: (2022-06-01)

Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease
by: Natasha de Alwis, et al.
Published: (2022-08-01)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
by: Sergey A. Siletsky
Published: (2023-05-01)

Urinary Acidification Does Not Explain the Absence of Nephrocalcinosis in a Mouse Model of Familial Hypomagnesaemia with Hypercalciuria and Nephrocalcinosis (FHHNC)
by: Amr Al-Shebel, et al.
Published: (2024-02-01)

Evaluation of hypomagnesaemia in diabetic patients with nephropathy in a reference clinical laboratory: a comparative cross sectional study
by: Sumaiya Qamar, et al.
Published: (2023-03-01)

The Combined Effects of Magnesium Oxide and Inulin on Intestinal Microbiota and Cecal Short-Chain Fatty Acids
by: Kanako Omori, et al.
Published: (2021-01-01)

Proton-pump inhibitors
by: Vasudevan G. Naidoo
Published: (2015-05-01)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
by: Carolla El Chamieh, et al.
Published: (2023-04-01)

Magnesium in chronic haemodialysis (MAGIC-HD): a study protocol for a randomised controlled trial to determine feasibility and safety of using increased dialysate magnesium concentrations to increase plasma magnesium concentrations in people treated with haemodialysis
by: Nicoline H J Leenders, et al.
Published: (2022-11-01)

Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations
by: Reuben Veysey-Smith, et al.
Published: (2021-11-01)

Inhibiting the proton pump: mechanisms, benefits, harms, and questions
by: Aronson, J
Published: (2016)

Oligowell-Inulin Complex
by: Muhammad Nasiruddin, Mansor
Published: (2017)

Pâté with Inulin Supplement
by: Irina U. Kusova, et al.
Published: (2022-06-01)

Safety of proton pump inhibitors
by: Ye. A. Losik
Published: (2016-08-01)

Pharmacogenetics of proton pump inhibitors
by: M. V. Leonova
Published: (2015-12-01)

Effects of Use of Proton Pump Inhibitors with Calcium Acetate on Serum Phosphorus Levels in Hemodialysis Patients
by: Deniz Çekiç, et al.
Published: (2023-09-01)

Kesan penggunaan inulin dan coklat berinulin terhadap pertumbuhan in vitro bifidobakteria (Effects of inulin and inulin containing chocolate on in vitro growth of bifidobacteria)
by: Norhayati Hussain,, et al.
Published: (2012)

The conformation of an inhibitor bound to the gastric proton pump.
by: Middleton, D, et al.
Published: (1997)

Mathematical modelling of inulin drying and extraction processes
by: Ergasheva Z. K., et al.
Published: (2023-01-01)

Case Report: Investigation and molecular genetic diagnosis of familial hypomagnesaemia [version 2; peer review: 1 approved, 3 approved with reservations]
by: Jamie Willows, et al.
Published: (2019-12-01)

RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017-12-01)